Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safety and PK of Telmisartan/HCTZ in Healthy Males
NCT02262780Phase 1Completed
- Sponsor
- Boehringer Ingelheim
- Start
- Dec 2003
- Primary completion
- Feb 2004
- Modality
- Small Molecules
01
Overview
Phase 1, open-label trial of telmisartan and hydrochlorothiazide in hypertension (HTN) (3 arms), sponsored by Boehringer Ingelheim. Primary endpoints: Number of patients with clinically relevant findings in physical examination, Number of patients with clinically relevant findings in vital signs and 4 more. Started Dec 2003; status: completed.
02
Drugs
telmisartanhydrochlorothiazide
03
Conditions
hypertension (HTN)
Beyond the preview
Go deeper on NCT02262780.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02262780.